文献速递血脂与心血管预防冠心病肺血管病与心包/心肌炎

美国动脉粥样硬化患者高强度他汀使用现况

High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

该回顾性队列研究基于美国商业健康计划理赔数据,纳入2018年1月31日至2019年1月31日确诊ASCVD的601,934例患者,评估2019年1月31日他汀使用情况及12个月依从性。结果显示仅22.5%使用高强度他汀,49.9%未用任何他汀,年轻、女性及非冠状动脉ASCVD患者使用不足更突出。

要点

  • ASCVD患者中仅22.5%使用高强度他汀,49.9%未用任何他汀。
  • 年轻、女性及高合并症评分患者更少被处方任何他汀。
  • 女性、老年及外周动脉疾病患者更少使用高强度他汀。

核心结论

  • 美国大型当代ASCVD队列中他汀使用不足显著,尤其年轻、女性和非冠状动脉ASCVD患者存在合理用药缺口。

研究设计与样本

  • 回顾性队列研究,查询商业健康计划药房和医疗理赔数据,纳入2018年1月31日至2019年1月31日确诊ASCVD患者601,934例。

主要发现

  • 601,934例患者中女性占41.7%,平均年龄67.5±13.3岁。
  • 22.5%使用高强度他汀,27.6%使用低或中等强度他汀,49.9%未用任何他汀。
  • 多因素分析显示年轻、女性及Charlson合并症评分更高者更少被处方任何他汀。
  • 他汀使用者中,女性、老年及外周动脉疾病患者更少使用高强度他汀,而既往一年心内科就诊增加高强度他汀使用几率。
  • 多数高强度他汀使用者达到高水平依从性。

临床怎么用

  • 应关注ASCVD患者他汀使用不足,尤其年轻、女性及非冠状动脉ASCVD人群。
  • 心内科就诊与高强度他汀使用增加相关,提示专科管理可能改善治疗强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preventive therapy among patients with established atherosclerotic cardiovascular disease (ASCVD) is generally underused. Whether new guideline recommendations and a focus on implementation have improved the use of high-intensity statins is unknown. OBJECTIVES: This study sought to evaluate the patterns and predictors of statin use among patients with ASCVD. METHODS: In this retrospective cohort study, pharmacy and medical claims data from a commercial health plan were queried for patients with established ASCVD between January 31, 2018, and January 31, 2019. Statin use on an index date of January 31, 2019, was evaluated, as was 12-month adherence and discontinuation. Multivariable logistic regression was used to determine independent associations with statin use of varying intensities. RESULTS: Of the 601,934 patients with established ASCVD, 41.7% were female, and the mean age was 67.5 ± 13.3 years. Overall, 22.5% of the cohort were on a high-intensity statin, 27.6% were on a low- or moderate-intensity statin, and 49.9% were not on any statin. In multivariable analysis, younger patients, female patients, and those with higher Charlson comorbidity score were less likely to be prescribed any statin. Among statin users, female patients, older patients, and those with peripheral artery disease were less likely to be on a high-intensity formulation, whereas a cardiology encounter in the prior year increased the odds. The majority of high-intensity stain users achieved high levels of adherence. CONCLUSIONS: Substantial underuse of statins persists in a large, insured, and contemporary cohort of patients with ASCVD from the United States. In particular, concerning gaps in appropriate statin use remain among younger patients, women, and those with noncoronary ASCVD.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Nelson AJ, Haynes K, Shambhu S, et al. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. J Am Coll Cardiol. 2022. PMID: 35512860. doi:10.1016/j.jacc.2022.02.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。